Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Restructuring
As part of internal restructuring within the group, Board of Directors of the Company at their meeting held on September 7, 2023 have approved acquisition of 100% shareholding in Strides Pharma Services Private Limited (SPSPL). SPSPL is currently a WOS of Arco Lab Private Limited, a WOS of the Company. Post the said acquisition, SPSPL shall be a WOS of the Company. Disclosure under Regulation 30 of SEBI Listing Regulations read with SEBI Circular of July 13, 2023 relating to the proposed transaction is enclosed.07-09-2023
